Sumitra Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 04-01-2025
- Paid Up Capital ₹ 4.00 Cr
as on 04-01-2025
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 Cr
as on 04-01-2025
- Revenue %
(FY 2023)
- Profit 62.86%
(FY 2023)
- Ebitda 91.43%
(FY 2023)
- Net Worth -20.00%
(FY 2023)
- Total Assets 32603.20%
(FY 2023)
About Sumitra Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company currently has active open charges totaling ₹5.00 Cr.
Venkatasasikumar Sanepalli, Rajamohan Sanepalle, Nilekh Sanepalle, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304AP2021PTC119909
- Company No.
119909
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 2021
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Cuddapah, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sumitra Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatasasikumar Sanepalli  | Managing Director | 01-Nov-2021 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajamohan Sanepalle | Director | 01-Nov-2021 | Current |
| Nilekh Sanepalle | Director | 01-Nov-2021 | Current |
| Satyanarayana Sanepalle | Director | 30-May-2024 | Current |
Financial Performance of Sumitra Laboratories.
Sumitra Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 62.86% increase in profit. The company's net worth observed a substantial decline by a decrease of 20%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sumitra Laboratories?
Unlock access to Sumitra Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sumitra Labs Private LimitedActive 4 years 6 monthsVenkatasasikumar Sanepalli and Rajamohan Sanepalle are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 27 Jun 2023 | ₹5.00 Cr | Open |
How Many Employees Work at Sumitra Laboratories?
Sumitra Laboratories has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sumitra Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sumitra Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
